Mitsubishi Chemical Elevates New Spanish Homecare Unit to Specified Subsidiary

An announcement from Mitsubishi Chemical Holdings ( (JP:4188) ) is now available.

Mitsubishi Chemical Group said its consolidated subsidiary Nippon Sanso Holdings has completed the acquisition of Spain-based home healthcare provider Esteve Teijin Healthcare, which has been renamed Nippon Sanso Homecare España. The deal was executed via European unit Nippon Sanso Euro-Holding through its Spanish arm Oximesa, making the acquired business a consolidated subsidiary.

Following a review of past capital transactions, Mitsubishi Chemical determined that Nippon Sanso Homecare España qualifies as a specified subsidiary because its capital now represents at least 10% of the parent’s capital. The financial impact of the acquisition and reclassification has already been reflected in the group’s full-year consolidated earnings forecast for the fiscal year ending March 2026, indicating the group had anticipated this expansion of its European home healthcare portfolio.

The most recent analyst rating on (JP:4188) stock is a Hold with a Yen900.00 price target. To see the full list of analyst forecasts on Mitsubishi Chemical Holdings stock, see the JP:4188 Stock Forecast page.

More about Mitsubishi Chemical Holdings

Mitsubishi Chemical Group Corporation is a diversified Japanese chemicals and materials conglomerate listed on the Tokyo Stock Exchange Prime Market, operating through subsidiaries such as Nippon Sanso Holdings in industrial gases and related healthcare services. The group focuses on global growth in specialty chemicals, advanced materials, and life-science–related businesses, leveraging overseas subsidiaries to expand its footprint in sectors such as home healthcare.

Average Trading Volume: 7,644,998

Technical Sentiment Signal: Buy

Current Market Cap: Yen1215.2B

For an in-depth examination of 4188 stock, go to TipRanks’ Overview page.